153 related articles for article (PubMed ID: 38175950)
21. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
[TBL] [Abstract][Full Text] [Related]
22. Economic evaluation of universal BCG vaccination of Japanese infants.
Rahman M; Sekimoto M; Takamatsu I; Hira K; Shimbo T; Toyoshima K; Fukui T
Int J Epidemiol; 2001 Apr; 30(2):380-5. PubMed ID: 11369746
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of Bacillus Calmette-Guérin vaccination against severe childhood tuberculosis in China: a case-based, multicenter retrospective study.
Liao Q; Zheng Y; Wang Y; Ye L; Liu X; Jiao W; Liu Y; Zhu Y; Jia J; Sun L; Shen A; Wan C
Int J Infect Dis; 2022 Aug; 121():113-119. PubMed ID: 35429637
[TBL] [Abstract][Full Text] [Related]
24. Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system.
Clothier HJ; Hosking L; Crawford NW; Russell M; Easton ML; Quinn JA; Buttery JP
Drug Saf; 2015 Jan; 38(1):79-86. PubMed ID: 25475539
[TBL] [Abstract][Full Text] [Related]
25. Impact of BCG Vaccination Disruptions During the COVID-19 Pandemic on Tuberculosis Incidence in Infants: A Nationwide Study in Brazil.
Procianoy GS; Cotrim MW; Cia LO; Behar PRP
J Pediatric Infect Dis Soc; 2024 Mar; 13(3):186-188. PubMed ID: 38330394
[TBL] [Abstract][Full Text] [Related]
26. The effect of bacille Calmette-Guérin vaccination at birth on immune response in China.
Pang Y; Kang W; Zhao A; Liu G; Du W; Xu M; Wang G; Zhao Y; Zheng S
Vaccine; 2015 Jan; 33(1):209-13. PubMed ID: 25454854
[TBL] [Abstract][Full Text] [Related]
27. The influence of neonatal Bacille Calmette-Guérin (BCG) immunisation on heterologous vaccine responses in infants.
Zimmermann P; Donath S; Perrett KP; Messina NL; Ritz N; Netea MG; Flanagan KL; van der Klis FRM; Curtis N;
Vaccine; 2019 Jun; 37(28):3735-3744. PubMed ID: 31153688
[TBL] [Abstract][Full Text] [Related]
28. [Progress in research of bacillus calmette-guerin vaccination and repeated vaccination].
You NN; Liu Q; Zhu LM; Lu W
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov; 39(11):1519-1523. PubMed ID: 30462965
[TBL] [Abstract][Full Text] [Related]
29. [Bacillus Calmette-Guérin (BCG) vaccine coverage in newborns and infants at risk before and after a change in BCG policy].
Parache C; Carcopino X; Gossot S; Retornaz K; Uters M; Mancini J; Garnier JM; Minodier P
Arch Pediatr; 2010 Apr; 17(4):359-65. PubMed ID: 20219333
[TBL] [Abstract][Full Text] [Related]
30. Adverse events following immunisation with bacille Calmette-Guérin vaccination: baseline data to inform monitoring in Australia following introduction of new unregistered BCG vaccine.
Hendry AJ; Dey A; Beard FH; Khandaker G; Hill R; Macartney KK
Commun Dis Intell Q Rep; 2016 Dec; 40(4):E470-E474. PubMed ID: 28043221
[TBL] [Abstract][Full Text] [Related]
31. An audit of BCG immunisation and tuberculin skin testing in Scotland. Scottish BCG Study Group.
Pell J; Capewell S
Health Bull (Edinb); 1996 Nov; 54(6):490-4. PubMed ID: 8990615
[TBL] [Abstract][Full Text] [Related]
32. A new neonatal BCG vaccination pathway in England: a mixed methods evaluation of its implementation.
Jones K; Chisnall G; Crocker-Buque T; Elliman D; Horwood J; Mounier-Jack S; Campbell CN; Saliba V; Chantler T
BMC Public Health; 2024 Apr; 24(1):1175. PubMed ID: 38671383
[TBL] [Abstract][Full Text] [Related]
33. Outbreak of Bacille Calmette-Guérin-related lymphadenitis in Saudi children at a university hospital after a change in the strain of vaccine.
Alrabiaah AA; Alsubaie SS; Bukhari EI; Gad A; Alzamel FA
Ann Saudi Med; 2012; 32(1):4-8. PubMed ID: 22156633
[TBL] [Abstract][Full Text] [Related]
34. The benefits and risks of bacille Calmette-Guérin vaccination among infants at high risk for both tuberculosis and severe combined immunodeficiency: assessment by Markov model.
Clark M; Cameron DW
BMC Pediatr; 2006 Mar; 6():5. PubMed ID: 16515694
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.
Faust L; Schreiber Y; Bocking N
BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446
[TBL] [Abstract][Full Text] [Related]
36. Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guérin (BCG) vaccines from different sources, Kazakhstan.
Favorov M; Ali M; Tursunbayeva A; Aitmagambetova I; Kilgore P; Ismailov S; Chorba T
PLoS One; 2012; 7(3):e32567. PubMed ID: 22427854
[TBL] [Abstract][Full Text] [Related]
37. Selective neonatal BCG vaccination.
Bakshi D; Sharief N
Acta Paediatr; 2004 Sep; 93(9):1207-9. PubMed ID: 15384885
[TBL] [Abstract][Full Text] [Related]
38. The lack of association between bacille Calmette-Guerin vaccination and clustering of Aboriginals with tuberculosis in western Canada.
Cook VJ; Hernández-Garduño E; Kunimoto D; Hershfield ES; Fanning EA; Hoeppner VH; Elwood RK; FitzGerald JM;
Can Respir J; 2005 Apr; 12(3):134-8. PubMed ID: 15875064
[TBL] [Abstract][Full Text] [Related]
39. Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries.
Brantsaeter AB; Romanus V; Andersen PH; Heldal E
Int J Tuberc Lung Dis; 2009 Apr; 13(4):440-5. PubMed ID: 19335948
[TBL] [Abstract][Full Text] [Related]
40. Non-specific effect of Bacille Calmette-Guérin vaccine on the immune response to routine immunisations.
Ritz N; Mui M; Balloch A; Curtis N
Vaccine; 2013 Jun; 31(30):3098-103. PubMed ID: 23583897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
